SPOTLIGHT: JAMA editor scolds Pfizer for subpoenas


The Journal of the American Medical Association lambasted Pfizer for threatening the "integrity" of its peer-review-based decision-making system by subpoenaing peer reviews for its Celebrex and Bextra defense. After posting that editorial on JAMA's website, editor Catherine DeAngelis told the WSJ Health Blog that a medical journal "may as well pack it up and go home" if it gave drugmakers the kind of information Pfizer wanted. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.